Authors: Deininger, M Ponisch, W Krahl, R Leiblein, S Edel, E Lange, T Fiedler, F Freund, M Franke, A Pasold, R von Grunhagen, U Herold, M Dolken, G Hoffmann, FA Uhle, R Schultze, W Steglich, J Schwarzer, A Richter, P Winkelmann, C Kettner, E Dachselt, K Subert, R Schwalbe, E Doepper, J Helbig, W Niederwieser, D

Citation: M. Deininger et al., Chemotherapy for mobilisation of Ph-negative progenitor cells from patients with CML: impact of different mobilisation regimens, BONE MAR TR, 27(11), 2001, pp. 1125-1132

Authors: Herold, M Strohl, J Assmann, M Eschenburg, H Franke, A Freund, M von Grunhagen, U Hahnfeld, S Hoffmann, FA Huhn, D Klinkenstein, C Knauf, W Pasold, R Hurtz, HJ Steglich, J Wolf, H

Citation: M. Herold et al., Acute toxicity of mitoxantrone, chlorambucil and prednisolone (MCP) versusMCP plus rituximab in low-grade non-Hodgkin's lymphoma - Interim results of a phase III trial, ONKOLOGIE, 23(2), 2000, pp. 164-166

Authors: Hoffken, G Pasold, R Pfluger, KH Finke, J Fauser, AA Szelenyi, H Wagner, J

Citation: G. Hoffken et al., An open, randomized, multicentre study comparing the use of low-dose ceftazidime or cefotaxime, both in combination with netilmicin, in febrile neutropenic patients, J ANTIMICRO, 44(3), 1999, pp. 367-376